Anti-amyloid therapies to treat Alzheimer’s Disease
#WeWontRest until new treatments can halt Alzheimer’s Disease in its tracks
Around 15,9 million people will be diagnosed with Alzheimer’s Disease in Europe by 2050. Total health and social care costs for Alzheimer’s in Europe are estimated to be over € 110bn
What is the potential breakthrough?
Whilst existing Alzheimer’s therapies only treat some of the symptoms of the disease, new treatments have the potential to delay the onset and / or progression of the disease itself.
By delaying the onset or progression of Alzheimer’s, patients are able to live an independent life for longer and enjoy more time with their friends and family.
What is the potential impact on Europe’s healthcare systems?
What is the potential impact on societies?
#WeWontRest until Alzheimer’s patients have a brighter future
Taking action together to ensure a better today and tomorrow for people with Alzheimer’s diseaseRead more
Disease never takes a break, so neither do we. We won’t rest until people around the world see a brighter tomorrow.Read more